Home
Conditions
Demyelinating Diseases

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies

Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.

NCT02750982

Conditions: Alzheimer Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, +46 more
Locations: Evergreen Healthcare Kirkland, Washington, United States

View Trial Details

Completed

Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions

NCT01953523

Conditions: Arthritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +43 more
Locations: California Stem Cell Treatment Center Rancho Mirage, California, United States

View Trial Details

Completed

A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis

NCT02064816

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Please contact the Merck KGaA Communication Center Darmstadt, Germany

View Trial Details

Completed

Effects Aquatic Exercises on Balance and Hand Function in Multiple Sclerosis

NCT03679806

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Dokuz Eylul University School of Physical Therapy and Rehabilitation Izmir, Turkey (Türkiye)

View Trial Details

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers

NCT03500627

Conditions: Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +22 more
Locations: Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States

View Trial Details

Completed

The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients

NCT03150966

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Drug Applied Research Center, Tabriz, Iran Tabriz, Iran

View Trial Details

Completed

Digitalization of Neurofunctional Tests Via a Mobile Application DAMS for Multiple Sclerosis Patients

NCT03148938

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Hôpital le Bocage Dijon, France

Hôpital Saint-Phllibert Lille, France

Hôpital La Timone Adulte Marseille, France

Hôpital Gui de Chauliac Montpellier, France

View Trial Details

Completed

Reliability, Validity and Clinical Utility of a Robotic Assessment for Proprioception

NCT03619642

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +16 more
Locations: Jessa Ziekenhuis Hasselt, Belgium

Revalidatie & MS Centrum Overpelt Overpelt, Belgium

View Trial Details

Completed

Observational Study to Assess the Correlation of EDSS With Quality of Life in MS Participants Treated With Natalizumab

NCT02386566

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Research Site Aarau, Switzerland

Research Site Basel, Switzerland

Research Site Bern, Switzerland

Research site - private practice Lucerne, Switzerland

View Trial Details

Completed

Urinary Markers of Detrusor Overactivity in Spina Bifida Patients

NCT02852317

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Central Nervous System Diseases, +28 more
Locations: Centre hospitalier universitaire de Rennes Rennes, France

View Trial Details

Demyelinating Diseases

Demyelinating Diseases trial results

Related conditions